What is he best known for?
The fields of study he is best known for:
Scrapie, Biochemistry, Virology, Prion protein and PrPSc Proteins are his primary areas of study.
His Scrapie study incorporates themes from In vitro, Recombinant DNA, Molecular biology, Hamster and Amyloid.
His work in the fields of Protease, Gene isoform, Sulfation and Protein folding overlaps with other areas such as Congo red.
Bioassay is closely connected to Transmissible mink encephalopathy in his research, which is encompassed under the umbrella topic of Virology.
His Prion protein study combines topics in areas such as Cerebrospinal fluid and Immunology.
His PrPSc Proteins study deals with Transmissible spongiform encephalopathy intersecting with Cell-free system.
His most cited work include:
- Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. (1419 citations)
- Cell-free formation of protease-resistant prion protein (774 citations)
- The most infectious prion protein particles (758 citations)
What are the main themes of his work throughout his whole career to date?
Byron Caughey mainly focuses on Scrapie, Virology, Biochemistry, Prion protein and In vitro.
Byron Caughey interconnects Molecular biology, Cell culture, Recombinant DNA and In vivo in the investigation of issues within Scrapie.
His Virology study which covers Transmissible spongiform encephalopathy that intersects with Chronic wasting disease.
Biochemistry is closely attributed to Amyloid in his research.
His Amyloid research integrates issues from Fibril, Protein aggregation and Glycosaminoglycan.
The study incorporates disciplines such as Immunology, Pathogenesis and Cell biology in addition to Prion protein.
He most often published in these fields:
- Scrapie (39.34%)
- Virology (34.84%)
- Biochemistry (29.92%)
What were the highlights of his more recent work (between 2017-2021)?
- Pathology (13.93%)
- Disease (13.11%)
- In vitro (17.62%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Pathology, Disease, In vitro, Cerebrospinal fluid and Synucleinopathies.
His research investigates the link between Disease and topics such as Neuroscience that cross with problems in Animal model.
His research integrates issues of Infectivity, Scrapie and Olfactory mucosa in his study of In vitro.
His Scrapie research is multidisciplinary, relying on both Cell, Cell culture and Encephalopathy.
Byron Caughey works mostly in the field of Biochemistry, limiting it down to topics relating to Progressive supranuclear palsy and, in certain cases, Thioflavin.
In his work, Genetically modified mouse is strongly intertwined with Virology, which is a subfield of Asymptomatic.
Between 2017 and 2021, his most popular works were:
- Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC (98 citations)
- Antisense oligonucleotides extend survival of prion-infected mice (42 citations)
- Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease. (41 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
Byron Caughey focuses on Pathology, Disease, Cerebrospinal fluid, Synucleinopathies and Dementia with Lewy bodies.
The Neurodegeneration research Byron Caughey does as part of his general Disease study is frequently linked to other disciplines of science, such as Tolerability, therefore creating a link between diverse domains of science.
His work in Cerebrospinal fluid addresses subjects such as Biomarker, which are connected to disciplines such as Protein Misfolding Cyclic Amplification, Transgene, Virology, Genetically modified mouse and Mesocricetus.
The concepts of his Synucleinopathies study are interwoven with issues in Lewy body and Biochemistry, Solubilization, Protein folding.
The Dementia with Lewy bodies study combines topics in areas such as In vitro and Synuclein.
Byron Caughey has included themes like Fibril, Alzheimer's disease and Recombinant DNA in his Molecular biology study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
